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This dataset in brief is related to the research letter entitled
“Nicotine-free, nontransgenic tobacco (Nicotiana tabacum L.) edited
by CRISPR-Cas9” [1]. Cured tobacco products with a signiﬁcantly
reduced nicotine content helps people to overcome their nicotine
addiction. Here we summarize additional data and method de-
scriptions of the generation process of a nicotine-free, non-
transgenic tobacco plant. This included the cloning, transformation
and regeneration of transgenic tobacco plants, followed by the
analysis of the nicotine content and genomic modiﬁcations caused
by CRISPR-Cas9 mediated gene editing. Subsequently, nicotine-free
plants were screened for loss of T-DNA cassette, i.e. nontransgenity.
Finally, a metabolic footprint was recorded by 1H NMR analysis.
© 2019 The Author(s). Published by Elsevier Inc. This is an open
access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).1. Data
The data shows the generation of a nicotine-free and nontransgenic tobacco plant by CRISPR-Cas9
mediated gene editing. After regeneration of plants and testing them for transgenity (Fig. 1) the
nicotine content was analyzed by GC measurements in wild type, T0 and T1 generations (Fig. 2).
Genomic analysis of T1 3.1 plant revealed that not all BBL (berberine bridge enzyme-like) loci were
knocked out (BBLe)(Fig. 3). Therefore, further generations were grown and analyzed. The nicotine level
of T3 4.11.1.2 plant was reduced to 0.04 mg g1 DW [1] (Fig. 4). This was additionally conﬁrmed by
GC-MSmeasurements (Fig. 5). The genomic analysis showed knockout of all BBL-loci [1]. The loss of the. Stehle).
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Speciﬁcations Table
Subject Plant Science
Speciﬁc subject area Plant Biotechnology, Plant genome editing
Type of data Table and Figures
How data were acquired Gibson cloning, Agrobacterium-mediated transformation, plant regeneration in tissue
culture, PCR, sanger sequencing, gas chromatography, gas chromatography mass
spectrometry, 1H NMR
Data format Analyzed
Parameters for data collection Tobacco plants were cultivated on hydro culture at 25 C under long day conditions (18
h light/6 h dark) with a light intensity of 110 mM m2 s1.
Description of data collection i) Nicotine content was analyzed by GC and GC-MS by extracting dried, grounded leaf
material ii) Sequence data were obtained by Sanger sequencing of PCR products iii)
metabolomic alterations were analyzed by 1H-NMR
Data source location Dortmund, Germany
Data accessibility With the article
Related research article Julia Schachtsiek, Felix Stehle
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Value of the Data
 First nicotine-free, nontransgenic tobacco plant that enables the production of non-addictive cured tobacco.
 Nicotine-free smoking products can support people to overcome nicotine addiction.
 This technology can be transferred to commercially used N. tabacum varieties as well as N. benthamiana to improve the
biotechnological production properties.
 First technology that eliminates the nicotine content while all other metabolites are not affected.
J. Schachtsiek, F. Stehle / Data in brief 26 (2019) 1043952T-DNA cassette was proven for plant T3 4.11.1.2 (Fig. 6). Finally, 1H NMR analysis showed no signiﬁcant
changes in primary metabolism (Figs. 7e9).
2. Experimental design, materials, and methods
2.1. Plant material
Nicotiana tabacum L. plants of the variety “Virginia Smoking Tobacco” (Strictly Medicinal Seeds LLC,
United States) were cultivated on hydro culture at 25 C under long day conditions (18 h light/6 h dark)Fig. 1. Selection for positive transformants in T1-generation: Seeds from T0 e plants were germinated on tissue paper and sprayed
with a 100 mg L1 PPT solution three times every two days. Seedlings of the wild type (left) died, seedlings from a transformed and
regenerated plant (right) survived.
Fig. 2. Amount of nicotine in wild type, T0 and T1 plants: (A) the amount of nicotine was measured with GC-FID of 200 mg dried and
grounded leaf material of plants extracted with MTBE. Amount of nicotine was calculated as mg per gram dry weight (DW). (B)
amount of nicotine in extracts of T1 plants.
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hypochlorite solution (1% active chlorine) and a few drops of Tween 20 for 10 minutes and washed
three times with water before they were plated out on Murashige and Skoog Medium (4.4 g L1
Murashige and Skoog Medium with Gamborg's Vitamins, 30 g L1 sucrose, pH 5.8).Fig. 3. Analysis of plant T1 3.1 on genomic level: Fragments of all six BBL genes (BBLa e BBLe) of the wild type (WT) and plant T1 3.1
were ampliﬁed and cloned into a vector by Gibson Assembly for sequencing. Inserted bases are highlighted in red leading to a frame
shift; PAM sequences are underlined and the gRNA sequence is shown in bold.
Fig. 4. GC chromatogram of crude extracts of Nicotiana tabacum leaves: comparison of crude extracts of tobacco leaves of the wild
type and the nicotine-free plant (T3 4.11.1.2). The red arrow marks the retention time of nicotine. (1.8 min - injection peak; 4.4 min -
internal standard (quinoline); 5.5 min e nicotine; 7.6 min e anatabine).
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For the delivery of the CRISPR cassette to N. tabacum plants with A. tumefaciens a binary vector
system was used [2]. The chosen sgRNA target sequence (GAAATCAGAGTAAGGTGCGG) for the BBL
genes was cloned into the vector pChimera according to the author's instructions and the resulting
vector was named pChimera-BBL. The gRNA chimera was subsequently cloned into the vector pCas9-
TPC according to the author's instructions resulting in the vector pCas9-BBL, which was used for
transformation experiments. All cloned vectors were veriﬁed by sequencing.
For the veriﬁcation of the targeted mutagenesis on genomic level, gene sequences of the six BBL
genes that include the target site were ampliﬁed with speciﬁc primers for each gene from genomic
DNA of wildtype and transgenic plants. For sequencing, the gene fragments were either cloned into the
vector pDionysos [3] by using the Gibson Assemblymethod or the PCR product was directly sequenced.
Used primers are listed in Table 1.
2.3. Plant transformation and regeneration
A. tumefaciens GV3101::pMP90 cells were transformed with the plasmid pCas9-BBL as described
previously [4]. Transformation of N. tabacum leaves and the followed plant regeneration were done
according to an existing protocol withminor changes [5]. Plants were inﬁltratedwith an OD600 nm of 0.1
and incubated for 3 days at long day conditions. For plant regeneration inﬁltrated leaves were surface
sterilized, cut into pieces and incubated on shooting medium (2.15 g L1 Murashige and SkoogMedium
with Gamborg's Vitamins, 30 g L1 sucrose, 0.1 mg L1 indole-3-butyric acid, 0.8 mg L1
Fig. 5. GC-MS analysis of plant extracts regarding the mass of nicotine: Extracts of the wild type (WT), plant T1 3.1 and T3 4.11.1.2
were analyzed with GC-MS measurements by the analysis of peaks corresponding to the m/z of nicotine (162.23 g/mol). Extracted
Ion chromatogram (EIC) of the mass of nicotine and the corresponding mass spectra are shown.
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Fig. 6. Test for non-transgenity of the nicotine-free plant: Leaf discs of the plants T1 4.11 and T3 4.11.1.2 were incubated in MS-
medium with 6 mg L1 PPT to test for the presence of the transformation cassette including the selection marker.
Fig. 7. 1H-NMR spectrum of wild type leaf-extract in MeOD: 20 mg leaf material of wild type leaves were freeze-dried and extracted
in MeOD. The region of aromatics (6 ppme9 ppm) is highlighted in the zoom-in insert, showing signals corresponding to nicotine
standard (see Fig. 9).
J. Schachtsiek, F. Stehle / Data in brief 26 (2019) 1043956benzylaminopurine, 250mg L1 carbenicillin, 6 mg L1 DL-phosphinothricin (PPT), 8 g L1 agar, pH 5.2)
under long day conditions. Developed shoots were transferred to rooting medium (2.15 g L1 Mura-
shige and Skoog Mediumwith Gamborg's Vitamins, 30 g L1 Sucrose, 0.5 mg L1 indole-3-butyric acid,
250 mg L1 carbenicillin, 6 mg L1 DL-phosphinothricin (PPT), 8 g L1 agar, pH 5.2) for approximately
10 days.
2.4. Test for transgenic plants
Seeds from regenerated plants were collected and seeded out for growing the T1 generation. To test
if these plants were transgenic, 7 days-old plantlets were sprayed with a solution of 100 mg L1 PPT
Fig. 8. 1H-NMR spectrum of nicotine-free plant leaf-extract in MeOD: 20 mg leaf material of nicotine-free plant leaves were freeze-
dried and extracted in MeOD. The region of aromatics (6 ppme9 ppm) is highlighted in the zoom-in insert, indicating the absence of
nicotine.
Fig. 9. 1H-NMR spectrum of nicotine in MeOD.
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Table 1
Primers used in the study.
Primer Name Sequence (50 / 30) purpose
BBL_gRNA_fwd ATTGGAAATCAGAGTAAGGTGCGG sgRNA target
BBL_gRNA_rev AAACCCGCACCTTACTCTGATTTC sgRNA target
SS129 CACAGGAAACAGCTATGAC Colony PCR pChimera-
BBL
SS42 TCCCAGGATTAGAATGATTAGG Colony PCR;
Sequencing
pChimera-BBL
SS43 CGACTAAGGGTTTCTTATATGC Colony PCR;
SS61 GAGCTCCAGGCCTCCCAGCTTTCG Sequencing pCas9-BBL
BBLa_Gib_fwd TCACACTGGCGGCCGCTCGAGCATGCATACTGCTACTGGA
GCTGTTAC
Gibson Assembly
pDionysos
BBLa_Gib_rev ATAACTAATTACATGATGCGGCCCTTGCAGGTCTCAGCAGTACTC Gibson Assembly
pDionysos
BBLb_Gib_fwd TCACACTGGCGGCCGCTCGAGCATGCATCTCTGCTACTGCAA
CTAGTGGA
Gibson Assembly
pDionysos
BBLb_Gib_rev ATAACTAATTACATGATGCGGCCCTATTTCCTCCTCCGCCACCTC Gibson Assembly
pDionysos
BBLc_Gib_fwd TCACACTGGCGGCCGCTCGAGCATGCATTGGAGCAGGA
GAAGGAGT
Gibson Assembly
pDionysos
BBLc_Gib_rev ATAACTAATTACATGATGCGGCCCTGGGCAACGTATTGTTTGGA Gibson Assembly
pDionysos
BBLd1_Gib_fwd TCACACTGGCGGCCGCTCGAGCATGCATTTCGGTCTCTGCAACAAC Gibson Assembly
pDionysos
BBLd1_Gib_rev ATAACTAATTACATGATGCGGCCCTGAAACTGGTCACGGTCTT Gibson Assembly
pDionysos
BBLd2_Gib_fwd TCACACTGGCGGCCGCTCGAGCATGCATCTCTTCAGCGTTT
GCTCATA
Gibson Assembly
pDionysos,
ampliﬁcation
BBLd2_Gib_rev ATAACTAATTACATGATGCGGCCCTCAAATCTACCGAAAC
ATCATCT
Gibson Assembly
pDionysos
BBLe_Gib_fwd TCACACTGGCGGCCGCTCGAGCATGCATGGAGCAGGAGGA
GTTACAAATC
Gibson Assembly
pDionysos
BBLe_Gib_rev ATAACTAATTACATGATGCGGCCCTTGGCGTCATCATTCTTAGCG Gibson Assembly
pDionysos
pDio_seq_fwd CGGTTTGTATTACTTCTTATTC Colony PCR
pDio_seq_rev GATGTGGGGGGAGGGCGTGAATGTA Colony PCR;
sequencing
PCR_BBLa_fwd ACTGCTACTGGAGCTGTTAC ampliﬁcation BBLa
BBLa_rev TGCAGGTCTCAGCAGTACTC ampliﬁcation BBLa
BBLa_seq_fwd GCACCTTTCATGCCGAAACC sequencing BBLa
PCR_BBLb_fwd TGGAGCAGGAGGTGGAGTTG ampliﬁcation BBLb
BBLb_rev ATTTCCTCCTCCGCCACCTC ampliﬁcation BBLb
BBLb_seq_fwd GCATCTTACATGCCGAAACC sequencing BBLb
PCR_BBLc_fwd TGGAGCAGGAGAAGGAGTTG ampliﬁcation BBLc
BBLc_rev GGGCAACGTATTGTTTGGAG ampliﬁcation BBLc
BBLc_seq_fwd GCATCTAACATGCCGAAACC sequencing BBLc
PCR_BBLd1_fwd TTCGGTCTCTGCAACAACTC ampliﬁcation BBLd1
BBLd1_rev GAAACTGGTCACGGTCTTGG ampliﬁcation BBLd1
BBLd1_seq ATTCGCAGCGTGCTCTAAAC sequencing BBLd2
BBLd2_seq CCGTCTCTGCTACAAATCTC sequencing BBLd2
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experiments.
Plants in T2 generation can be tested for the loss of the CRISPR-Cas9 cassette. For this purpose leaves
of T2 generation plants were surface sterilized for 10 minutes with sodium hypochlorite (0.5% active
chlorine) and a few drops of Tween 20 followed by three washing steps with water. Leaf discs were cut
out with a cork borer and incubated on selection medium (4.4 g L1 Murashige and Skoog Medium
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Additionally, validation of the loss of the CRISPR cassette was done with PCR. Genomic DNA of the
plants was isolated and ampliﬁcation of the CRISPR cassette was done by the use of primers SS43 and
SS61.2.5. Plant extracts
For the extraction of alkaloids a modiﬁed version of the extraction protocol from Lewis et al. [6] was
used. For the extraction 50 mg or 100 mg of ground leaves with 1 mL of a 2 N NaOH to moisten the
sample in a glass vessel with a screw-cap. After 15minutes of incubation time 5mL of methyl tert-butyl
ether (MTBE) containing 0.4 mgml1 quinoline used as an internal standard were added to the sample.
Samples were incubated for 2.5 h with shaking at 200 rpm. For layer separation the glass vessels were
stored without shaking overnight. The MTBE layer was used for gas chromatographic analysis.2.6. Gas chromatographic analysis
Measurements of plant extracts were done with an Agilent Technologies 7890A GC system
equipped with a ﬂame ionization detector (FID) set to 300 C and a VF-5ms column (CP8944;
30 m 0.25 mm, ID 0.25 mm). H2 ﬂowwas set to 30 mLmin1, Air Flow to 400ml min1 and N2 ﬂow to
30 mL min1. Injector temperature was set to 250 C and 1 mL of the sample was injected in splitless
mode. Initial oven temperature was set to 110 C, held for 1 minute and increased afterwards to 200 C
with a rate of 10 C/min followed by an increase to 300 C in steps of 25 C/min. The temperature of
300 C was held for 10 minutes.
For GC-MS measurements a Thermo Scientiﬁc Trace GC Ultra systemwith a ISQ mass spectrometer
and a TG-SQC column (Thermo Scientiﬁc; 15m 0,25mm, ID 0,25 mm)was used. Injector temperature
was set to 90 C and 1 mL of the sample was injected in splitless mode. Initial oven temperature was set
to 60 C for 1 min, followed by an increase of the temperature to 200 C with a rate of 10 C/min.
Afterwards the temperature was increased to 300 C with a rate of 25 C/min which was held for 10
minutes. Helium was used as a carrier gas with a ﬂow of 0.7 ml min1.2.7. 1H-NMR analysis
For NMR analysis, 20 mg of freeze-dried leaf material of the wild type and the nicotine-free plant or
10 mg of nicotine standard were mixed with 1 mL methanol-D4 and vortexed for one minute. After
ultrasonication for 15 minutes the samples were centrifuged at 13,000 g for 5 minutes. Around 600 mL
of the supernatant was ﬁlled into a 3 mm NMR-tube. 1H-NMR measurements were done at 25 C and
600 MHz with the Bruker AV 600 Avance III HD (Cryoprobe) spectrometer. The data were analyzed
using TopSpin 4.0.Acknowledgments
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